We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+0.72%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.47%
10 Year Est. Return
+236.85%
AUM
$768M
AUM Growth
-$80.1M
Cap. Flow
-$27.1M
Cap. Flow %
-3.53%
Top 10 Hldgs %
60.99%
Holding
740
New
85
Increased
91
Reduced
143
Closed
103

Sector Composition

Rank Sector Weight
1 Financials 25.36%
2 Technology 10.73%
3 Consumer Discretionary 9.26%
4 Communication Services 3.87%
5 Industrials 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFF icon
376
International Flavors & Fragrances
IFF
$22.5B
$23K ﹤0.01%
186
+1
+0.5% +$128
QQQ icon
377
Invesco QQQ Trust
QQQ
$480B
$23K ﹤0.01%
120
PXD
378
DELISTED
Pioneer Natural Resource Co.
PXD
$23K ﹤0.01%
172
+45
+35% +$5.95K
ALXN
379
DELISTED
Alexion Pharmaceuticals
ALXN
$23K ﹤0.01%
230
ADI icon
380
Analog Devices
ADI
$184B
$22K ﹤0.01%
200
AVGO icon
381
Broadcom
AVGO
$1.99T
$22K ﹤0.01%
800
AZO icon
382
AutoZone
AZO
$50.1B
$22K ﹤0.01%
20
BIDU icon
383
Baidu
BIDU
$37.7B
$22K ﹤0.01%
216
-2,052
-90% -$220K
DG icon
384
Dollar General
DG
$28B
$22K ﹤0.01%
138
IQV icon
385
IQVIA
IQV
$38.9B
$22K ﹤0.01%
150
SYK icon
386
Stryker
SYK
$129B
$22K ﹤0.01%
100
-1,900
-95% -$408K
DAL icon
387
Delta Air Lines
DAL
$61.3B
$21K ﹤0.01%
351
-4,170
-92% -$247K
SAP icon
388
SAP
SAP
$228B
$21K ﹤0.01%
178
SSB icon
389
SouthState Bank Corp
SSB
$10.6B
$21K ﹤0.01%
278
+1
+0.4% +$75
WBA
390
DELISTED
Walgreens Boots Alliance
WBA
$21K ﹤0.01%
375
EAD
391
Allspring Income Opportunities Fund
EAD
$378M
$20K ﹤0.01%
2,407
GLW icon
392
Corning
GLW
$135B
$20K ﹤0.01%
758
ITOT icon
393
iShares Core S&P Total US Stock Market ETF
ITOT
$97.3B
$20K ﹤0.01%
328
+10
+3% +$670
PZT icon
394
Invesco New York AMT-Free Municipal Bond ETF
PZT
$139M
$20K ﹤0.01%
785
+5
+0.6% +$127
GWPH
395
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$20K ﹤0.01%
170
AOS icon
396
A.O. Smith
AOS
$8.59B
$19K ﹤0.01%
402
+2
+0.5% +$92
AVY icon
397
Avery Dennison
AVY
$13.4B
$19K ﹤0.01%
167
-120
-42% -$13.7K
BIV icon
398
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$19K ﹤0.01%
220
-25
-10% -$2.18K
SSNC icon
399
SS&C Technologies
SSNC
$18.6B
$19K ﹤0.01%
+355
New +$18.1K
WAB icon
400
Wabtec
WAB
$50B
$19K ﹤0.01%
264
-10
-4% -$711

Similar funds

Pathstone Family Office's Q3 2019 Portfolio in Review

As of Q3 2019, Pathstone Family Office held 740 positions worth $768M, down 9.5% from $848M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Pathstone Family Office withdrew a net $27.1M in Q3 2019, closing 103 positions and reducing 143 holdings. Its most notable exit was UroGen Pharma, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Pathstone Family Office opened a new position in Xylem worth $529K.

  • Pathstone Family Office's largest Q3 2019 buy was Xylem: 6,643 shares worth $529K.
  • Pathstone Family Office added most to Vanguard S&P 500 ETF in Q3 2019, an estimated $1.75M increase.
  • Pathstone Family Office's biggest Q3 2019 reduction was Royal Bank of Canada, cutting an estimated $11.3M.
  • Pathstone Family Office fully exited UroGen Pharma in Q3 2019, selling an estimated $1.47M.
  • Pathstone Family Office's ten largest holdings make up 61% of its $768M portfolio in Q3 2019.
  • Pathstone Family Office opened 85 new positions and closed 103 in Q3 2019.
  • Pathstone Family Office's portfolio value fell 9.5% quarter-over-quarter to $768M.

Based on Pathstone Family Office's 13F filing for Q3 2019, filed 13 Nov 2019.